Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo

  • Thomas Luke
    Viral and Rickettsial Diseases Department, Navy Medical Research Center, The Henry Jackson Foundation for the Advancement of Military Medicine, Silver Spring, MD 20910, USA.
  • Hua Wu
    SAB Biotherapeutics Inc., Sioux Falls, SD 57104, USA.
  • Jincun Zhao
    Department of Microbiology, University of Iowa, Iowa City, IA 52242, USA.
  • Rudragouda Channappanavar
    Department of Microbiology, University of Iowa, Iowa City, IA 52242, USA.
  • Christopher M. Coleman
    Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD 21201, USA.
  • Jin-An Jiao
    SAB Biotherapeutics Inc., Sioux Falls, SD 57104, USA.
  • Hiroaki Matsushita
    SAB Biotherapeutics Inc., Sioux Falls, SD 57104, USA.
  • Ye Liu
    Novavax Inc., Gaithersburg, MD 20878, USA.
  • Elena N. Postnikova
    Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD 21702, USA.
  • Britini L. Ork
    Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD 21702, USA.
  • Gregory Glenn
    Novavax Inc., Gaithersburg, MD 20878, USA.
  • David Flyer
    Novavax Inc., Gaithersburg, MD 20878, USA.
  • Gabriel Defang
    Department of Virology, Naval Medical Research Unit-3, Cairo FPO AP 09835, Egypt.
  • Kanakatte Raviprakash
    Department of Virology, Naval Medical Research Unit-3, Cairo FPO AP 09835, Egypt.
  • Tadeusz Kochel
    Viral and Rickettsial Diseases Department, Navy Medical Research Center, Silver Spring, MD 20910, USA.
  • Jonathan Wang
    Thermo Fisher Scientific, South San Francisco, CA 94080, USA.
  • Wensheng Nie
    Thermo Fisher Scientific, South San Francisco, CA 94080, USA.
  • Gale Smith
    Novavax Inc., Gaithersburg, MD 20878, USA.
  • Lisa E. Hensley
    Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD 21702, USA.
  • Gene G. Olinger
    Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD 21702, USA.
  • Jens H. Kuhn
    Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD 21702, USA.
  • Michael R. Holbrook
    Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD 21702, USA.
  • Reed F. Johnson
    Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD 21702, USA.
  • Stanley Perlman
    Department of Microbiology, University of Iowa, Iowa City, IA 52242, USA.
  • Eddie Sullivan
    SAB Biotherapeutics Inc., Sioux Falls, SD 57104, USA.
  • Matthew B. Frieman
    Department of Microbiology and Immunology, University of Maryland, School of Medicine, Baltimore, MD 21201, USA.

抄録

<jats:p>Anti–MERS-CoV human IgG produced from transchromosomic bovines neutralizes MERS-CoV in vitro and in vivo.</jats:p>

収録刊行物

  • Science Translational Medicine

    Science Translational Medicine 8 (326), 326ra321-, 2016-02-17

    American Association for the Advancement of Science (AAAS)

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ